← Back to home

Neurologic, endocrine and pancreatic disease, multisystem, infantile-onset 2

Clinical trials for Neurologic, endocrine and pancreatic disease, multisystem, infantile-onset 2 explained in plain language.

Never miss a new study

Get alerted when new Neurologic, endocrine and pancreatic disease, multisystem, infantile-onset 2 trials appear

Sign up with your email to follow new studies for Neurologic, endocrine and pancreatic disease, multisystem, infantile-onset 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Rare disease study pulled before starting: scientists sought clues in cell stress

Knowledge-focused Cancelled

This study was planned to learn how certain rare genetic mutations disrupt protein production and cause severe diseases affecting the lungs, liver, brain, and digestion. Researchers would have used cells from patients to measure protein levels and stress responses. However, the s…

Matched conditions: NEUROLOGIC, ENDOCRINE AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2

Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused

Last updated Jun 27, 2026 07:51 UTC

Neurologic, endocrine and pancreatic disease, multisystem, infantile-onset 2

Get alerted when new Neurologic, endocrine and pancreatic disease, multisystem, infantile-onset 2 trials appear

Rare disease study pulled before starting: scientists sought clues in cell stress